Polymeric nanofibers: Targeted gastro-retentive drug delivery systems

Journal of Drug Targeting

Volumn 23, Issue 2, 2015, Pages 109-124

  Malik, Rafi ^a   Garg, Tarun ^a   Goyal, Amit K ^a   Rath, Goutam ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Controlled drug delivery; Floating system; Gastro retentive drug delivery system; Nanofibers

Indexed keywords

ALGINIC ACID; CARBOMER; CHITOSAN; NANOCARRIER; NANOCOMPOSITE; NANOFIBER; PECTIN; POLYLACTIC ACID; POLYMER; DELAYED RELEASE FORMULATION; DRUG CARRIER;

DENSITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG PENETRATION; HUMAN; INFRARED SPECTROSCOPY; MUCOADHESION; POLYMERIZATION; POROSITY; PRIORITY JOURNAL; REVIEW; SCANNING ELECTRON MICROSCOPY; SCINTIGRAPHY; SURFACE PROPERTY; TENSILE STRENGTH; ADMINISTRATION AND DOSAGE; BIOAVAILABILITY; CHEMISTRY; DELAYED RELEASE FORMULATION; GASTRIC MUCOSA; METABOLISM; PHARMACOKINETICS; STOMACH ABSORPTION;

BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GASTRIC ABSORPTION; GASTRIC MUCOSA; HUMANS; NANOFIBERS; POLYMERS; POROSITY; SURFACE PROPERTIES;

EID: 84921274009     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2014.965715     Document Type: Review

References (86)

1. Garg T, Singh O, Arora S, Murthy R. Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 2012b;29:1-63.
2. Dixit N. Floating drug delivery system. J Curr Pharm Res 2011;7:6-20.
3. Waterman KC. A critical review of gastric retentive controlled drug delivery. Pharma Dev Technol 2007;12:1-10.
4. Garg T, Goyal AK. Liposomes: targeted and controlled delivery system. Drug Deliv Lett 2014;4:62-71.
5. Garg R, Gupta G. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res 2008;7:1055-66.
6. Garg T, Singh S, Goyal AK. Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 2013;30:369-409.
7. Parnami N, Garg T, Rath G, Goyal AK. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol 2013;41:276-81.
8. Kaur M, Malik B, Garg T, et al. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv 2014. [Epub ahead of print].
9. 2 coating on electrospun polymer nanofibers. Adv Mater 2009;21:1252-6.
10. Son YJ, Kim WJ, Yoo HS. Therapeutic applications of electrospun nanofibers for drug delivery systems. Arch Pharmacal Res 2014;37:69-78.
11. Sharma A, Gupta A, Rath G, et al. Electrospun composite nanofiber-based transmucosal patch for anti-diabetic drug delivery. J Mater Chem B 2013;1:3410-18.
12. Kaur M, Garg T, Rath G, Goyal AK. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 2014;31:49-88.
13. Grewal H, Dhakate SR, Goyal AK, et al. Development of transmucosal patch using nanofibers. Artif Cells Blood Substit Biotechnol 2012;40:146-50.
14. Ramakrishna S, Fujihara K, Teo W-E, et al. Electrospun nanofibers: solving global issues. Mater Today 2006;9:40-50.
15. Garg T, Goyal AK, Arora, S, Murthy R. Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett 2012;2:251-61.
16. Clarke G, Newton J, Short M. Gastrointestinal transit of pellets of differing size and density. Int J Pharm 1993;100:81-92.
17. Badoni A, Ojha A, Gnanarajan G, Kothiyal P. Review on gastro retentive drug delivery system. Pharma Innovation 2012;1:32-42.
18. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Rel 2000;63:235-59.
19. Jiménez-Castellanos MR, Zia H, Rhodes C. Mucoadhesive drug delivery systems. Drug Dev Ind Pharm 1993;19:143-94.
20. Park K, Robinson JR. Bioadhesive polymers as platforms for oralcontrolled drug delivery: method to study bioadhesion. Int J Pharm 1984;19:107-27.
21. Prajapati VD, Jani GK, Khutliwala TA, Zala BS. Raft forming system - an upcoming approach of gastroretentive drug delivery system. J Control Rel 2013;168:151-65.
22. Arora S, Ali J, Ahuja A, et al. Floating drug delivery systems: a review. AAPS PharmSciTech, 2005;6:E372-90.
23. Kim JO, Oberoi HS, Desale S, et al. Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery. J Drug Target 2013;21:981-93.
24. Groning R, Berntgen M. Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule. Die Pharmazie 1996;51:328-31.
25. Gröning R, Berntgen M, Georgarakis M. Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. Eur J Pharm Biopharm 1998;46:285-91.
26. Jain AK, Jain SK. Development and characterization of nanolipo-beads-based dual drug delivery system for H. pylori targeting. J Drug Target 2013;21:593-603.
27. Petrik S, Maly M. Production nozzle-less electrospinning nanofiber technology. MRS Proceedings; 2009; Cambridge University Press.
28. Fong H, Chun I, Reneker D. Beaded nanofibers formed during electrospinning. Polymer 1999;40:4585-92.
29. Kim B, Park H, Lee S-H, Sigmund WM. Poly(acrylic acid) nanofibers by electrospinning. Mater Lett 2005;59:829-32.
30. Huang L, Nagapudi KP, Apkarian R, Chaikof EL. Engineered collagen-PEO nanofibers and fabrics. J Biomater Sci Polymer Ed 2001;12:979-93.
31. Zong X, Kim K, Fang D, et al. Structure and process relationship of electrospun bioabsorbable nanofiber membranes. Polymer 2002;43:4403-12.
32. Mit-Uppatham C, Nithitanakul M, Supaphol P. Ultrafine electrospun polyamide-6 fibers: effect of solution conditions on morphology and average fiber diameter. Macromol Chem Phys 2004;205:2327-38.
33. Jun Z, Hou H, Schaper A, et al. Poly-L-lactide nanofibers by electrospinning-Iinfluence of solution viscosity and electrical conductivity on fiber diameter and fiber morphology. e-Polymers 2003;9:1-9.
34. Ramakrishna S, Fujihara K, Teo W-E, et al. An introduction to electrospinning and nanofibers. Singapore: World Scientific; 2005.
35. Zhang L, Wang S, Zhang M, Sun J. Nanocarriers for oral drug delivery. J Drug Target 2013;21:515-27.
36. Zhang Y, Feng Y, Huang Z, et al. Fabrication of porous electrospun nanofibres. Nanotechnology 2006;17:901-10.
37. Huang Z-M, Zhang Y-Z, Kotaki M, Ramakrishna S. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos Sci Technol 2003;63:2223-53.
38. Kataria K, Sharma A, Garg T, et al. Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett 2014;4:79-86.
39. Goyal G, Garg T, Malik B, et al. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv 2013. [Epub ahead of print].
40. Singh H, Sharma R, Joshi M, et al. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol 2014. [Epub ahead of print].
41. Meng Z, Xu X, Zheng W, et al. Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system. Colloid Surface B 2011;84:97-102.
42. Goyal AK, Rath G, Garg T. Nanotechnological approaches for genetic immunization. DNA RNA Nanobiotechnol Med 2013;2013:67-120.
43. Garg T, Singh O, Arora S, Murthy R. Patented microencapsulation techniques and its application. J Pharm Res 2011;4:2097-102.
44. Garg T, Goyal AK. Iontophoresis: drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett 2012;2:270-80.
45. Jena A, Gupta K. Pore volume of nanofiber nonwovens. Int Nonwovens J 2005;14:25-30.
46. Hunley MT, Long TE. Electrospinning functional nanoscale fibers: a perspective for the future. Polymer Int 2008;57:385-9.
47. Cui Q, Dong X, Wang J, Li M. Direct fabrication of cerium oxide hollow nanofibers by electrospinning. J Rare Earths 2008;26:664-9.
48. Gestos A, Whitten PG, Spinks GM, Wallace GG. Crosslinking neat ultrathin films and nanofibres of pH-responsive poly (acrylic acid) by UV radiation. Soft Matter 2010;6:1045-52.
49. Hamman JH. Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. Marine Drugs 2010;8:1305-22.
50. Bhattarai N, Edmondson D, Veiseh O, et al. Electrospun chitosanbased nanofibers and their cellular compatibility. Biomaterials 2005;26:6176-84.
51. Gatti JW, Smithgall MC, Paranjape SM, et al. Using electrospun poly (ethylene-oxide) nanofibers for improved retention and efficacy of bacteriolytic antibiotics. Biomedical Microdev 2013;15:887-93.
52. Uyar T, Hacaloglu J, Besenbacher F. Electrospun polyethylene oxide (PEO) nanofibers containing cyclodextrin inclusion complex. J Nanosci Nanotechnol 2011;11:3949-58.
53. Garg T, Goyal AK. Biomaterial-based scaffolds - current status and future directions. Expert Opin Drug Deliv 2014;11:767-89.
54. Bhardwaj N, Kundu SC. Electrospinning: a fascinating fiber fabrication technique. Biotechnol Adv 2010;28:325-47.
55. Frenot A, Chronakis IS. Polymer nanofibers assembled by electrospinning. Curr Opin Colloid Interface Sci 2003;8:64-75.
56. Wise DL. Handbook of pharmaceutical controlled release technology. Boca Raton, FL: CRC Press; 2000.
57. Grainger SJ, El-Sayed ME. Stimuli-sensitive particles for drug delivery. Singapore: World Scientific; 2010.
58. Hetangi R, Vishnu P, Moin M. In situ gel as a novel approach of gastroretentive drug delivery. Int J Pharm Life Sci 2010;1:440-7.
59. Beneke CE, Viljoen AM, Hamman JH. Polymeric plant-derived excipients in drug delivery. Molecules 2009;14:2602-20.
60. Alborzi S, Lim LT, Kakuda Y. Electrospinning of sodium alginatepectin ultrafine fibers. J Food Sci 2010;75:C100-7.
61. Seo H, Matsumoto H, Hara S, et al. Preparation of polysaccharide nanofiber fabrics by electrospray deposition: additive effects of poly(ethylene oxide). Polymer J 2005;37:391-8.
62. Nirmal H, Bakliwal S, Pawar S. In-situ gel: new trends in controlled and sustained drug delivery system. Int J PharmTech Res 2010;2:1398-408.
63. Baz M, Samant M, Zekki H, et al. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice. Clin Vaccine Immunol 2012;19:209-18.
64. Shao C, Yang X, Guan H, et al. Electrospun nanofibers of NiO/ZnO composite. Inorg Chem Commun 2004;7:625-7.
65. Zhu J, Wei S, Chen X, et al. Electrospun polyimide nanocomposite fibers reinforced with core - shell Fe-FeO nanoparticles. J Phys Chem C 2010;114:8844-50.
66. 4 nanofibers toward hierarchical and repetitive superstructures by polymer-controlled mineralization reactions. Nano Lett 2003;3:379-82.
67. 2/ZnO composite nanofibers by electrospinning and their photocatalytic property. Mater Chem Phys 2010;121:432-9.
68. Lim SK, Lee SK, Hwang SH, Kim H. Photocatalytic deposition of silver nanoparticles onto organic/inorganic composite nanofibers. Macromol Mater Eng 2006;291:1265-70.
69. Zeng J, Aigner A, Czubayko F, et al. Poly(vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the retardation of enzyme release by additional polymer coatings. Biomacromolecules 2005;6:1484-8.
70. Yang D, Li Y, Nie J. Preparation of gelatin/PVA nanofibers and their potential application in controlled release of drugs. Carbohydr Polym 2007;69:538-43.
71. Yang G, Wang J, Li L, et al. Electrospun micelles/drug-loaded nanofibers for time-programmed multi-agent release. Macromol Biosci 2014;14:965-76.
72. Sultana S, Khan MR, Kumar M, et al. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review. J Drug Target 2013;21:107-25.
73. Tyagi C, Tomar L, Choonara YE, et al. Electrospun nanofiber matrix with a mucoadhesive backing film for oramucosal drug delivery. Int J Mat Mech Manufact 2014;2:81-5.
74. Sharma A, Gupta A, Rath G, et al. Electrospun composite nanofiber-based transmucosal patch for anti-diabetic drug delivery. J Mater Chem B 2013;1:3410-18.
75. Puppi D, Piras AM, Detta N, et al. Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid. Acta Biomater 2010;6:1258-68.
76. Hamori M, Yoshimatsu S, Hukuchi Y, et al. Preparation and pharmaceutical evaluation of nano-fiber matrix supported drug delivery system using the solvent-based electrospinning method. Int J Pharm 2014;464:243-51.
77. Chen R, Huang C, Ke Q, et al. Preparation and characterization of coaxial electrospun thermoplastic polyurethane/collagen compound nanofibers for tissue engineering applications. Colloid Surface B 2010;79:315-25.
78. Park CG, Kim E, Park M, et al. A nanofibrous sheet-based system for linear delivery of nifedipine. J Control Release 2011;149:250-7.
79. Atchison JS, Schauer CL. Fabrication and characterization of electrospun pristine and fluorescent composite poly(acrylic acid) ultra-fine fibers. JEFF 2012;7:50-5.
80. Baba R, Angammana C, Jayaram S, Lim L. Electrospinning of alginate and poly-ethylene oxide blends using pulsed electric fields to fabricate chopped nanofibres. Proc ESA Ann Meet Electrostat 2010;2:1-8.
81. Jaiswal AK, Kadam SS, Soni VP, Bellare JR. Improved functionalization of electrospun PLLA/gelatin scaffold by alternate soaking method for bone tissue engineering. Appl Surface Sci 2013;268:477-88.
82. Geng X, Kwon O-H, Jang J. Electrospinning of chitosan dissolved in concentrated acetic acid solution. Biomaterials 2005;26:5427-32.
83. Maretschek S, Greiner A, Kissel T. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. J Control Release 2008;127:180-7.
84. Loh XJ, Peh P, Liao S, et al. Controlled drug release from biodegradable thermoresponsive physical hydrogel nanofibers. J Control Release 2010;143:175-82.
85. Moreno I, González-González V, Romero-García J. Control release of lactate dehydrogenase encapsulated in poly(vinyl alcohol) nanofibers via electrospinning. Eur Polymer J 2011;47:1264-72.
86. Jiang H, Hu Y, Li Y, et al. A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. J Control Release 2005;108:237-43.